LDT Oversight Remains Under CLIA, for Now
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Enforcement-nir
Subscribe today for access to
Articles and Reports
Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
Already a member? Log in here
Already a member? Log in here
Already a member? Log in here
Already a member? Log in here
Already a member? Log in here
Already a member? Log in here
University of Miami Settles Lab Testing False Claim Charges for $22 Million
...
Already a member? Log in here
Health Care Data Breaches Hit a New High in First Half of 2021
...
Already a member? Log in here
Texas Provider Pays $214K for Violating Federal COVID-19 Workplace Protocols
...
Already a member? Log in here
University of Miami Settles Lab Testing False Claim Charges for $22 Million
...
Already a member? Log in here